These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18315915)

  • 41. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients.
    Morecki S; Yacovlev E; Gelfand Y; Eizik O; Slavin S
    Exp Hematol; 2007 May; 35(5):748-56. PubMed ID: 17577924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Influence of donor Treg cells on GVHD and GVL effects after allogeneic bone marrow transplantation in mice].
    Cao J; Chen C; Zeng LY; Li ZY; Cheng H; Pan XY; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):181-4. PubMed ID: 20137143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promotion of fetal liver cell engraftment in irradiated mice by activated T lymphocytes.
    Plotnicky H; Touraine JL
    Bone Marrow Transplant; 1993 Oct; 12(4):307-14. PubMed ID: 8275029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism.
    Mapara MY; Kim YM; Marx J; Sykes M
    Transplantation; 2003 Jul; 76(2):297-305. PubMed ID: 12883182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].
    Xu KL; Ju JP; Pan XY; Du B; Li ZY; Lu QX
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):372-5. PubMed ID: 12941194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses.
    Ji YH; Weiss L; Zeira M; Abdul-Hai A; Reich S; Schuger L; Slavin S
    Bone Marrow Transplant; 2003 Sep; 32(5):495-504. PubMed ID: 12942096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
    Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
    Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance.
    Mercadante AC; Perobelli SM; Alves AP; Gonçalves-Silva T; Mello W; Gomes-Santos AC; Miyoshi A; Azevedo V; Faria AM; Bonomo A
    J Immunol; 2014 Feb; 192(4):1928-37. PubMed ID: 24453248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The analysis of the influencing factors of mortality rate in the transplantation of mouse bone marrow].
    Yan X; Ye T; Hu X; Jia D; Li B; Chen Y; Wang X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Feb; 29(1):112-5. PubMed ID: 22404019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Preliminary study on graft versus leukemia effect of camouflage of mice bone marrow transplantation with methoxy polyethylene glycol modification].
    Long H; Tang SQ; Zhang XF
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):377-80. PubMed ID: 15924758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bystander injury of host lymphoid tissue during murine graft-verus-host disease is mediated by nitric oxide.
    Hoffman RA; Langrehr JM; Berry LM; White DA; Schattenfroh NC; McCarthy SA; Simmons RL
    Transplantation; 1996 Feb; 61(4):610-8. PubMed ID: 8610389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of different irradiation doses on the establishment of murine cGVHD model after MHC matched spleen stem cell transplantation].
    Li XM; Zhu H; Tang B; Chu YN; Liu YL; Zhou F; Zhang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1115-9. PubMed ID: 25130839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of graft-versus-host disease by intrathymic injection of recipient-type splenocytes into donor.
    Vaidya S; Wang CC; Roorda C; Billings A; Rajaraman S; Fish JC
    Transplantation; 1996 Nov; 62(9):1366-8. PubMed ID: 8932289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo.
    Sadeghi B; Heshmati Y; Khoein B; Kaipe H; Uzunel M; Walfridsson J; Ringdén O
    Cytotherapy; 2015 Dec; 17(12):1732-45. PubMed ID: 26481415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on transient graft-versus-host disease in BALB/c nude mice injected with allogeneic C57BL/6 splenocytes.
    Kihara T; Morita H; Kitano Y
    J Dermatol Sci; 1996 Jan; 11(1):76-83. PubMed ID: 8867771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.